Beta Bionics' iLet product offers a simplified diabetes treatment, but shares have plunged 60% since the IPO due to a non-inspiring 2025 outlook, indicating potential lost market momentum. Despite ...

One woman's quest to say ‘thank you’ led to the colonel who ran her refugee camp and the aircraft maintainer who may have ...